STOCK TITAN

Silo Pharma, Inc. (SILO) Net Income by Year

SILO

Silo Pharma, Inc. reported a net loss of $4.2M in fiscal year 2025. This represents an increase of 3.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $4.5M net loss. The table below carries 12 fiscal years, from 2011 to 2025, and the quarters Silo Pharma, Inc. has filed alongside them.

FY2025 annual
Net Income -$4.2M
YoY +3.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SILO Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY25POS AMFY24POS AMFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1310-KFY1210-KFY1110-K
Net Income-$4.5M-$4.2M+3.8%-$4.4M-18.7%-$3.7M+5.3%-$3.9M-200.1%$3.9M+228.5%-$3.0M-199.8%-$1.0M-4.5%-$969K-371.9%$357KN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

SILO Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'24POS AMQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$833K+30.8%-$1.6M-59.7%-$882K+49.1%-$1.1M-19.6%-$1.2M-29.2%-$1.0M-28.7%-$1.7M-54.4%-$929K-40.7%-$932K+8.0%-$802K+11.6%-$1.1M+32.6%-$660K+32.9%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Silo Pharma, Inc. financials

Frequently Asked Questions

What was Silo Pharma, Inc.'s net income in fiscal year 2025?

Silo Pharma, Inc. reported a net loss of $4.2M in fiscal year 2025.

How fast is Silo Pharma, Inc.'s net income growing?

Silo Pharma, Inc. (SILO) net income rose by 3.8% year over year, from -$4.4M to -$4.2M in fiscal year 2025.

What is Silo Pharma, Inc.'s net income over the last twelve months?

Silo Pharma, Inc. (SILO) reported a $4.5M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Silo Pharma, Inc. (SILO) reported -$833K in net income in Q2 2026. This represents an increase of 30.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Silo Pharma, Inc. (SILO) reported on that line in every period on record.